Skip to Main Content

Paper Details

Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk.
Alzheimers Dement (Amst)
4
2022
AD, Alzheimer's disease, CpG, TBCA, TREM2, cytosine-phosphate-, epigenetic loci, guanine, triggering receptor expressed on myeloid cells 2, tubulin-specific chaperone A
Author NameAffiliation
Caroline HaywardMRC Human Genetics Unit Institute of Genetics and Cancer University of Edinburgh Edinburgh UK.
Simon LovestoneDepartment of Psychiatry University of Oxford Oxford UK.
Simon LovestoneNeurodegeneration Johnson and Johnson Medical Ltd Wokingham UK.
Riccardo E MarioniCentre for Genomic and Experimental Medicine Institute of Genetics and Cancer, University of Edinburgh Edinburgh UK.
  • 1 - 4

Datasets

Release 1.2